Country for PR: United Kingdom
Contributor: PR Newswire Europe
Friday, January 29 2021 - 03:42
AsiaNet
Alfasigma to expand its digital footprint
BOLOGNA, Italy, Jan. 28, 2021 /PRNewswire-AsiaNet/ --

Online doctorAsyou, a web platform entirely dedicated to physicians 

The website optimizes research on the most important and autoritative medical 
databases such as Pubmed, ICTRP and ClinicalTrials.gov. 
 
An entirely new area presents online courses for physicians on several 
different topics 

 
Alfasigma has recently launched a number of digital activities that expand its 
web presence and improves its touchpoints around the world.


doctorAsyou – online at www.doctorasyou.com - is a web portal entirely 
dedicated to physicians with two main areas: online scientific research and 
medical training development.

The Website database optimizes and simplifies online research process of 
scientific medical information, for a continuous updating, necessary to face 
clinical decisions in the best possible way.

The database is updated daily and returns a total of about 30 million 
abstracts, combining the three most authoritative databases in the world such 
as PubmedICTRP  and ClinicalTrials.gov. 

This comprehensive database is able to discover articles and original 
researches, keeping users up to date with health and medical developments in 
order to stay ahead and improve patient care. It's available also a virtual 
library, useful to    manage in different folders all saved publication and 
search interests. doctorAsyou is focused on first-hand clinical information, in 
fact it filteres out non relevant documents types from PubMed (e.g. video, 
editorials, books) and improves with other sources.

Pier Vincenzo Colli, CEO of Alfasigma declares: "doctorAsyou is a relevant 
investment that Alfasigma has done in favor of the global scientific community 
in order to facilitate research work and continuous medical development of 
healthcare professionals. It's another important step in our digital 
transformation entirely dedicated to serve psysicians and reserarrchers around 
the world. The scope goes beyond our focus in gastro-intestinal, vascular and 
rheumatological therapeutic areas, because also this project is consistent with 
our corporate social responsibility effort to support research and development 
in all scientific areas."  

The second area is made up with high-level training programs that permit to 
advance professional careers and build users' confidence with a 3-6 month 
action-oriented learning experience made up of cohort and self-paced courses, 
designed and taught by a global experts community. Educational activities are 
delivered in a wide variety of formats that are intended to facilitate paying 
attention and remembering what is learned. At the same time the courses can be 
attended anytime and anywhere. A number of topics are covered such as Writing 
in Science, Medication Adherence Definition, Tools, & Statistics, Internet of 
Medical Things in Healthcare, Communication Skills For Surgeons, A Data-Driven 
Approach to Improve Patient Care and others.

More info.

Pubmed comprises over 30 million citations for biomedical literature from 
MEDLINE, life science journals, and online books. PubMed citations and 
abstracts include the fields of biomedicine and health, covering branches of 
the life sciences, behavioral sciences, chemical sciences, and bioengineering. 

ICTRP: International Clinical Trial Registry Platform is a service set up by 
the World Health Organisation (WHO) to ensure that information regarding 
clinical trials is accessible to all those involved in healthcare decision 
making. 

Clinicaltrials.gov: it's a database of privately and publicly funded clinical 
studies conducted in 50 states and in 216 countries. ClinicalTrials.gov is a 
resource provided by the U.S.  national Library of Medicine and it includes 
around 350,000 research studies.

About Alfasigma

Privately owned, Alfasigma is one of the leading Italian pharmaceutical 
companies, present in over 90 countries, through distributors and subsidiaries 
and has a workforce of around 3,000 people, R&D laboratories, and 5 production 
plants. 

In Italy, Alfasigma is a leader in the market for prescription products where, 
in addition to the strong focus on gastrointestinal, it is present in many 
primary care therapeutic areas. Alfasigma also produces and markets 
self-medication products, nutraceuticals and food supplements. 

More information is available at the corporate website 
https://www.alfasigma.com    

Logo - https://mma.prnewswire.com/media/1325576/Alfasigma_Logo.jpg 

Source: Alfasigma
Translations

Japanese